StockData
MediciNova Inc logo

MediciNova Inc (MNOV) stock

MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $65.96MP/E –Yield –

MediciNova price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MediciNova's price to sales ratio was 75.4× on Nov 11, 2026, against 66.2× a year earlier. Over the last 2 years it ranged from 7.9× to 469.4×, with a median of 76.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202675.4×+12.1
2024Apr 30, 202463.3×+30.8
2022Apr 29, 202232.4×+24.3
2014Jul 31, 20148.1×−443.1
2013Oct 31, 2013451.2×–

More MediciNova figures

See a number that looks wrong?